[Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose; D001892:Camphanes / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D002784:Cholesterol / Q000097:blood; D004195:Disease Models, Animal; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D005905:Glyburide / Q000494:pharmacology; D006943:Hyperglycemia / Q000188:drug therapy; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D007275:Injections, Intravenous; D008112:Liver Glycogen / Q000378:metabolism; D051379:Mice; D008862:Microsomes, Liver / Q000378:metabolism; D010088:Oxidoreductases / Q000378:metabolism; D010743:Phospholipids / Q000097:blood; D011817:Rabbits; D051381:Rats; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D014044:Tolbutamide / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D001892:Camphanes; D007004:Hypoglycemic Agents; D008112:Liver Glycogen; D010743:Phospholipids; D013453:Sulfonylurea Compounds; D014280:Triglycerides; D002784:Cholesterol; D014044:Tolbutamide; D010088:Oxidoreductases; D005905:Glyburide
Glibornurid, ein neues hochwirksames Antidiabetikum. Pharmakologische und biochemische Vergleichsumtersuchun gen an verschiedenen Tierspezies und an tierexperimentellen Modellen.